Bionic Eye Technologies

Bionic Eye Technologies was a private U.S. medical device company developing implantable neurostimulation and visual prosthesis technologies intended to restore functional vision in blind or severely visually impaired patients. Publicly available descriptions indicate a focus on retinal or related neural-interface devices, with intellectual property covering micro-fabricated electrode arrays and minimally invasive implantation methods for neural tissue. The company appears to have operated from Ithaca, New York and was categorized by business databases as a therapeutic devices company. There is no clear evidence of an approved commercial product or an advanced clinical-stage pipeline, so the company is best characterized as an early-stage ophthalmology/neurotechnology developer. Corporate registry aggregators indicate the entity became inactive in 2024.